Browse > Article

Cancer Gene Therapy. History and Major Developments  

정인재 (덕성여자대학교 약학대학)
Publication Information
Toxicological Research / v.19, no.3, 2003 , pp. 247-257 More about this Journal
Abstract
Medicine is undergoing a revolution in the understanding of the mechanisms through which disease processes develop. The advent of genetics and molecular biology to oncology not only is providing surrogate predictors of therapy response and survival which are forming the basis for selection among established treatment options, but is providing targets for new directions in therapy as well. Molecular modification of somatic cells for the purposes of protecting the normal cells from the toxicity of cancer chemotherapy, for the sensitization of the tumor cells to therapy and use of conditionally replicating viral vector have been new directions of cancer treatment which have reached the clinical arena. Advances in molecular pharmacology and vector design summarized in this paper may provide solutions to some of the existing problems in the technology of gene transfer therapy. Continued basic research into the biological basis of human disease, systemic studies of the application of these discoveries to therapy and the improvement of vector for gene delivery all combined may result in advances in this important field of therapy over the next few years.
Keywords
Cancer gene therapy; Viral vector; Gene transfer.;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Head and neck cancer: gene therapy approaches. Part II: genes delivered /
[ Nemunaitis,J.;O'Brien,J. ] / Expert Opinion on Biological Therapy   DOI   ScienceOn
2 Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression /
[ Pandha,H.S.;Martin,L.A.;Rigg,A.;Hurst,H.C.;Stamp,G.W.;Sikora,K.;Lemoine,N.R. ] / J. Clin. Onc.   DOI
3 Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients /
[ Lillo,R.;Ramirez,M.;Alvarez,A.;Santos,S.;Garcia-Castro,J.;Fernandez de Velasco,J.;Aviles,M.J.;Gomez-Pineda,A.;Diez,J.L.;Balas,A.;Vicario,J.L.;Bueren,J.A.;Garcia-Sanchez,F. ] / Cancer Res.
4 Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine /
[ Crystal,R.G.;Hirschowitz,E.;Lieberman,M.;Daly,J.;Kazam,E.;Henschke,C.;Yankelevitz,D.;Kemeny,N.;Silverstein,R.;Ohwada,A.;Russi,T.;Mastrangeli,A.;Sanders,A.;Cooke,J.;Harvey,B.G. ] / Human Gene Ther.   DOI   ScienceOn
5 Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of nonsmall cell lung cancer cells /
[ Horio,Y.;Hasegawa,Y.;Sekido,Y.;Takahashi,M.;Roth,J.A.;Shimokata,K. ] / Cancer Gene Ther.   DOI   ScienceOn
6 Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: [aradigm for a prospective cancer control strategy /
[ Moolten,F.L. ] / Cancer Res.
7 Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase /
[ Huber,B.E.;Austin,E.A.;Richards,C.A.;Davis,S.T.;Good,S.S. ] / Proc. Natl. Acad. Sci. USA   DOI   ScienceOn
8 Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease /
[ Cavazzana-Calvo,M.;Hacein-Beym,S.;de Saint Basile,G.;Gross,F.;Yvon,E.;Nusbaum,P.;Selz,F.;Hue,C.;Certain,S.;Casanova,J.L.;Bousso,P.;Deistm,F.L.;Fischer,A. ] / Science   DOI
9 Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells /
[ Chung,I.;Schwartz,P.E.;Crystal,R.G.;Pizzorno,G.;Leavitt,J.;Deisseroth,A.B. ] / Cancer Gene Ther.   DOI   ScienceOn
10 Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma /
[ Clayman,G.L.;el-Naggar,A.K.;Lippman,S.M.;Henderson,Y.C.;Frederick,M.;Merritt,J.A.;Zumstein,L.A.;Timmons,T.M.;Liu,T.J.;Ginsberg,L.;Roth,J.A.;Hong,W.K.;Bruso,P.;Goepfert,H. ] / J. Clin. Onc.   DOI
11 Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer /
[ Nemunaitis,J.;Swisher,S.G.;Timmons,T.;Connors,D.;Mack,M.;Doerksen,L.;Weill,D.;Wait,J.;Lawrence,D.D.;Kemp,B.L.;Fossella,F.;Glisson,B.S.;Hong,W.K.;Khuri,F.R.;Kurie,J.M.;Lee,J.J.;Lee,J.S.;Nguyen,D.M.;Nesbitt,J.C.;Perez-Soler,R.;Pisters,K.M.;Putnam,J.B.;Richli,W.R.;Shin,D.M.;Walsh,G.L. ] / J. Clin. Onc.   DOI
12 Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells /
[ Rodriguez,R.;Schuur,E.R.;Lim,H.Y.;Henderson,G.A.;Simons,J.W.;Henderson,D.R. ] / Cancer Res.
13 Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging /
[ Seth,P.;Brinkmann,U.;Schwartz,G.N.;Katayose,D.;Gress,R.;Pastan,I.;Cowan,K. ] / Cancer Res.
14 Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 status /
[ Petit,T.;Davidson,K.K.;Cerna,C.;Lawrence,R.A.;Von Hoff,D.D.;Heise,C.;Kirn,D.;Izbicka,E. ] / Anti-cancer Drugs   DOI   ScienceOn
15 Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas /
[ Mineta,T.;Rabkin,S.D.;Yazaki,T.;Hunter,W.D.;Martuza,R.L. ] / Nature Med.   DOI   ScienceOn
16 The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified /
[ Freeman,S.M.;Abboud,C.N.;Whartenby,K.A.;Packman,C.H.;Koeplin,D.S.;Moolten,F.L.;Abraham,G.N ] / Cancer Res.
17 Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 millon-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation /
[ Garcia-Sanchez,F.;Pizzomo,G.;Fu,S.Q.;Nanakorn,T.;Krause,D.S.;Liang,J.;Adams,E.;Leffert,J.J.;Yin,L.H.;Cooperberg,M.R.;Hanania,E.;Wang,W.L.;Won,J.H.;Peng,X.Y.;Cote,R.;Brown,R.;Burtness,B.;Giles,R.;Crystal,R.;Deisseroth,A.B. ] / Blood
18 Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer results of a multicenter phase II study. /
[ Schuler,M.;Herrmann,R.;De Greve,J.L.;Stewart,A.K.;Gatzemeier,U.;Stewart,D.J.;Laufman,L.;Gralla,R.;Kuball,J.;Buhl,R.;Heussel,C.P.;Kommoss,F.;Perruchoud,A.P.;Shepherd,F.A.;Fritz,M.A.;Horowitz,J.A.;Huber,C.;Rochlitz,C. ] / J. Clin. Onc.   DOI
19 Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma /
[ Rainov,N.G.;Fels,C.;Droege,J.W.;Schafer,C.;Kramm,C.M.;Chou,T.C. ] / Cancer Gene Ther.   DOI   ScienceOn
20 A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group /
[ Shand,N.;Weber,F.;Mariani,L.;Bernstein,M.;Gianella-Borradori,A.;Long,Z.;Sorensen,A.G.;Barbier,N. ] / Human Gene Ther.   DOI   ScienceOn
21 Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo /
[ Nishizaki,M.;Meyn,R.E.;Levy,L.B.;Atkinson,E.N.;White,R.A.;Roth,J.A.;Ji,L. ] / Clin. Cancer Res.
22 In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase /
[ Chung-Faye,G.A.;Chen,M.J.;Green,N.K.;Burton,A.;Anderson,D.;Mautner,V.;Searle,P.F.;Kerr,D.J. ] / Gene Ther.   DOI   ScienceOn
23 Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer /
[ Nemunaitism,J.;Khuri,F.;Ganly,I.;Arseneau,J.;Posner,M.;Vokes,E.;Kuhn,J.;McCarty,T.;Landers,S.;Blackburn,A.;Romel,L.;Randlev,B.;Kaye,S.;Kim,D. ] / J. Clin. Onc.   DOI
24 In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase /
[ Huber,B.E.;Austin,E.A.;Good,S.S.;Knick,V.C.;Tibbels,S.;Richards,C.A. ] / Cancer Res.
25 Progress towards gene therapy for cancer /
[ Marchisone,C.;Pfeffer,U.;Del Grosso,F.;Noonan,D.M.;Santi,L.;Albin,I.A. ] / J. Exp. Clin. Cancer Res.
26 Center for Biologics Evaluation and Research, Biological Response Modifiers Advisory Committee /
[ FDA (Food and Drug Administration) ] / SUMMARY MINUTES Meeting #33
27 Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer /
[ Rahman,Z.;Kavanagh,J.;Champlin,R.;Giles,R.;Hanania,E.;Fu,S.;Zu,Z.;Mehra,R.;Holmes,F.;Kudelka,A.;Claxton,D.;Verschraegen,C.;Gajewski,J.;Andreeff,M.;Heimfeld,S.;Berenson,R.;Ellerson,D.;Calvert,L.;Mechetner,E.;Holzmayer,T.;Dayne,A.;Hamer,J.;Bachier,C.;Ostrove,J.;Deisseroth,A. ] / Clinical Cancer Res.
28 Clinical protocol. A Phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects /
[ MacGregor,R.R. ] / Human Gene Ther.
29 The cytotoxic effect of replication competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the Breast, ovary and colon /
[ Akbulut,H.;Zhang,L.;Tang,Y.;Deisseroth,A. ] / Cancer Gene Ther.   DOI   ScienceOn
30 Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer /
[ Hassan,W.;Sanford,M.A.;Woo,S.L.;Chen,S.H.;Hall,S.J. ] / World J. Urol.   DOI   ScienceOn
31 Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer /
[ Freytag,S.O.;Khil,M.;Stricker,H.;Peabody,J.;Menon,M.;DePeralta-Venturina,M.;Nafziger,D.;Pegg,J.;Paielli,D.;Brown,S.;Barton,K.;Lu,M.;Aguilar-Cordova,E.;Kim,J.H. ] / Cancer Res.
32 Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions /
[ Touraine,R.L.;Vahanian,N.;Ramsey,W.J.;Blaese,R.M. ] / Human Gene Ther.   DOI   ScienceOn
33 Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors /
[ Kafri,T.;Blomer,U.;Peterson,D.A.;Gage,F.H.;Verma,I.M. ] / Nature Gen.   DOI   ScienceOn
34 A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy /
[ Freytag,S.O.;Rogulski,K.R.;Paielli,D.L.;Gilbert,J.D.;Kim,J.H. ] / Human Gene Ther.   DOI   ScienceOn
35 Center for Biologics Evaluation and Research, Biological Response Modifiers Advisory Committee /
[ FDA (Food and Drug Administration) ] / SUMMARY MINUTES Meeting #34
36 Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model /
[ Freytag,S.O.;Paielli,D.;Wing,M.;Rogulski,K.;Brown,S.;Kolozsvary,A.;Seely,J.;Barton,K.;Dragovic,A.;Kim,J.H. ] / Int. J. Rad. Onc. Bio. Phys.   DOI
37 Cancer gene therapy: fringe or cutting edge? /
[ McCormick,F. ] / Nat. Rev. Cancer   DOI   ScienceOn
38 An adenovirus mutant that replicates selectively in p53-deficient human tumor cells /
[ Bischoff,J.R.;Kim,D.H.;Williams,A.;Heise,C.;Horn,S.;Muna,M.;Ng,L.;Nye,J.A.;Sampson-Johannes,A.;Fattaey,A.;McCormick,F. ] / Science   DOI
39 p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication /
[ Harada,J.N.;Berk,A.J. ] / J. Virol.
40 Gene therapy death prompts review of adenovirus vector /
[ Marshall,E. ] / Science   DOI
41 Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer. a pilot trial /
[ Deisseroth,A.B.;Holmes,F.;Hortobagyi,G.;Champlin,R. ] / Human Gene Ther.   DOI   ScienceOn
42 Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer /
[ Swisher,S.G.;Roth,J.A.;Nemunaitis,J.;Lawrence,D.D.;Kemp,B.L.;Carrasco,C.H.;Connors,D.G.;El-Naggar,A.K.;Fossella,F.;Glisson,B.S.;Hong,W.K.;Khuri,F.R.;Kurie,J.M.;Lee,J.J.;Lee,J.S.;Mack,M.;Merritt,J.A.;Nguyen,D.M.;Nesbitt,J.C.;Perez-Soler,R.;Pisters,K.M.;Putnam,B.Jr.;Richli,W.R.;Savin,M.;Waugh,M.K. ] / J. National Cancer Institute   DOI
43 Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colonyforming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy /
[ Hanania,E.G.Giles,R.E.;Kavanagh,J.;Fu,S.Q.;Ellerson,D.;Zu,Z.;Wang,T.;Su,Y.;Kudelka,A.;Rahman,Z.;Holmes,F.;Hortobagyi,G.;Claxton,D.;Bachier,C.;Thall,P.;Cheng,S.;Hester,J.;Ostrove,J.M.;Bird,R.E.;Chang,A.;Korbling,M.;Seong,D.;Cote,R.;Holzmayer,T.;Deisseroth,A.B. ] / Proc. Natl. Acad. Sci. USA   DOI   ScienceOn
44 Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal inteference in a malignant gloma model /
[ Moriuchi,S.;Wolfe,D.;Tamura,M.;Yoshimine,T.;Miura,F.;Cohen,J.B.;Glorioso,J.C. ] / Gene Ther.   DOI   ScienceOn